Literature DB >> 10905528

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.

E R Myers1, D C McCrory, K Nanda, L Bastian, D B Matchar.   

Abstract

The authors constructed a Markov model as part of a systematic review of cervical cytology conducted at the Duke University Evidence-based Practice Center (Durham, North Carolina) between October 1997 and September 1998. The model incorporated states for human papillomavirus infection (HPV), low- and high-grade squamous intraepithelial lesions, and cervical cancer stages I-IV to simulate the natural history of HPV infection in a cohort of women from ages 15 to 85 years. The age-specific incidence rate of HPV, and regression and progression rates of HPV and squamous intraepithelial lesions, were obtained from the literature. The effects of varying natural history parameters on cervical cancer incidence were evaluated by using sensitivity analysis. The base-case model resulted in a lifetime cervical cancer risk of 3.67% and a lifetime cervical cancer mortality risk of 1.26%, with a peak incidence of 81/100,000 at age 50 years. Age-specific distributions of precursors were similar to reported data. Lifetime risk of cancer was most sensitive to the incidence of HPV and the probability of rapid HPV progression to high-grade lesions (two- to threefold variations in risk). The model approximates the age-specific incidence of cervical cancer and provides a tool for evaluating the natural history of HPV infection and cervical cancer carcinogenesis as well as the effectiveness and cost-effectiveness of primary and secondary prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905528     DOI: 10.1093/oxfordjournals.aje.a010166

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  93 in total

1.  Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.

Authors:  Naiyana Praditsitthikorn; Yot Teerawattananon; Sripen Tantivess; Supon Limwattananon; Arthorn Riewpaiboon; Saibua Chichareon; Nantakan Ieumwananonthachai; Viroj Tangcharoensathien
Journal:  Pharmacoeconomics       Date:  2011-09       Impact factor: 4.981

2.  Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer.

Authors:  James L Klosky; Brianne Favaro; Kelly R Peck; Jessica L Simmons; Kathryn M Russell; Daniel M Green; Melissa M Hudson
Journal:  J Cancer Surviv       Date:  2015-11-16       Impact factor: 4.442

3.  [Proven and new methods in the treatment of genital warts].

Authors:  P Schneede; R Waidelich
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

4.  Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.

Authors:  Rosa Legood; Alastair Gray; Jane Wolstenholme; Sue Moss
Journal:  BMJ       Date:  2006-01-06

5.  Rates and probabilities in economic modelling: transformation, translation and appropriate application.

Authors:  Rachael L Fleurence; Christopher S Hollenbeak
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 6.  Human papillomavirus vaccine and cervical cancer prevention.

Authors:  Ana Oaknin; Ma Pilar Barretina
Journal:  Clin Transl Oncol       Date:  2008-12       Impact factor: 3.405

7.  Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer.

Authors:  James L Klosky; Kathryn M Russell; Kristin E Canavera; Heather L Gammel; Jason R Hodges; Rebecca H Foster; Gilbert R Parra; Jessica L Simmons; Daniel M Green; Melissa M Hudson
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-27

8.  Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer.

Authors:  James L Klosky; Kathryn M Russell; Jessica L Simmons; Rebecca H Foster; Kelly Peck; Daniel M Green; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2015-04-20       Impact factor: 3.167

Review 9.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

10.  Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study.

Authors:  Maria Grandahl; Tanja Tydén; Maria Gottvall; Ragnar Westerling; Marie Oscarsson
Journal:  Health Expect       Date:  2012-12-16       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.